Healthcare Facilities company Dr. Agarwal's Eye Hospital announced Q1FY27 results Financial Highlights: Revenue from Operations: The company reported revenue from operations of Rs 142.97 crore in Q1FY27, representing a growth of 19.13% on a QoQ basis compared to Rs 120.01 crore in Q4FY26 and a 22.28% increase on a YoY basis compared to Rs 116.92 crore in Q1FY26. Total Income: Total income for Q1FY27 stood at Rs 144.93 crore, showing a QoQ increase of 19.21% from Rs 121.58 crore in Q4FY26 and a YoY increase of 23.11% from Rs 117.72 crore in Q1FY26. Profit Before Tax: The company achieved a profit before tax of Rs 30.96 crore in Q1FY27, which is a growth of 45.69% over Rs 21.25 crore in Q4FY26 and a 33.51% growth over Rs 23.19 crore in Q1FY26. Net Profit After Tax: Net profit for the period reached Rs 23.38 crore in Q1FY27, marking an increase of 43.97% QoQ from Rs 16.24 crore in Q4FY26 and an increase of 35.46% YoY from Rs 17.26 crore in Q1FY26. EBITDA: Earnings before interest, tax, depreciation, and amortisation (EBITDA) reached Rs 45.22 crore in Q1FY27, reflecting a QoQ growth of 28.10% from Rs 35.30 crore in Q4FY26 and a YoY growth of 19.22% from Rs 37.93 crore in Q1FY26. Total Comprehensive Income: This parameter stood at Rs 22.91 crore for Q1FY27, compared to Rs 16.38 crore in Q4FY26 and Rs 17.30 crore in Q1FY26. Earnings Per Share (EPS): Basic and diluted EPS for Q1FY27 was Rs 48.38, compared to Rs 33.60 in Q4FY26 and Rs 36.72 in Q1FY26. Business Highlights: Scheme of Amalgamation: The proposed scheme of amalgamation with its holding company, Dr. Agarwal's Health Care Limited ("AHCL"), received approval from the requisite majority of equity shareholders, secured creditors, and unsecured creditors in meetings held on July 02, 2026. The scheme remains subject to final sanction from the Hon'ble NCLT and other regulatory completions. Preferential Allotment: Following the issuance of 1,32,827 equity shares at a price of Rs 5,270 per share (totaling Rs 70 crore) to AHCL in September 2025, the company has utilised Rs 28.20 crore as per the terms of objects approved by shareholders. The balance unutilised portion as of Q1FY27 has been temporarily invested in debt mutual funds. Audit Appointment: The Board has re-appointed M/s. B Y & Associates, Practicing Cost Accountants, as the Cost Auditors for the financial year FY27. Result PDF
Healthcare Facilities company Dr. Agarwal's Eye Hospital announced Q4FY26 & FY26 results Financial Highlights: Revenue from operations: Q4FY26: Rs 120.01 crore, compared to Rs 99.83 crore in Q4FY25 (YoY increase of 20.22%). Compared to Q3FY26 (Rs 116.22 crore), this reflects a QoQ increase of 3.26%. FY26: Rs 470.87 crore, compared to Rs 397.15 crore in FY25 (YoY increase of 18.56%). Profit before tax: Q4FY26: Rs 21.25 crore, compared to Rs 18.60 crore in Q4FY25 (YoY increase of 14.25%). Compared to Q3FY26 (Rs 23.45 crore), this reflects a QoQ decrease of 9.38%. FY26: Rs 93.61 crore, compared to Rs 70.70 crore in FY25 (YoY increase of 32.40%). Profit after tax: Q4FY26: Rs 16.24 crore, compared to Rs 15.99 crore in Q4FY25 (YoY increase of 1.56%). Compared to Q3FY26 (Rs 17.28 crore), this reflects a QoQ decrease of 6.02%. FY26: Rs 70.10 crore, compared to Rs 54.65 crore in FY25 (YoY increase of 28.27%). Earnings per share (EPS): Q4FY26: Rs 33.60, compared to Rs 34.02 in Q4FY25 (YoY decrease of 1.23%). Compared to Q3FY26 (Rs 35.76), this reflects a QoQ decrease of 6.04%. FY26: Rs 147.02, compared to Rs 116.28 in FY25 (YoY increase of 26.44%). Business Highlights: Dividend: The Board of Directors has recommended a final dividend of Rs 4 per equity share (40%) for the financial year ended March 31, 2026, subject to approval by the members at the ensuing Annual General Meeting. This is in addition to the interim dividend of Rs 3 per equity share (30%) declared on October 30, 2025, bringing the total dividend for FY26 to Rs 7.00 (70%) per equity share. Amalgamation Update: The Board of Directors, at its meeting held on August 27, 2025, approved a proposed scheme of amalgamation with its Holding Company, Dr. Agarwal's Health Care Limited (AHCL), which is subject to necessary approvals. Preferential Issue: During the year, the Company issued 1,32,827 equity shares at a price of Rs 5,270 per share via a preferential issue to Dr. Agarwal's Health Care Limited, aggregating to Rs 70 crore. As of March 31, 2026, Rs 22.16 crore has been utilized, and the balance unutilized portion is temporarily invested in debt mutual funds. Result PDF
Healthcare Facilities company Dr. Agarwal's Eye Hospital announced Q3FY26 results Revenue: Rs 115.22 crore against Rs 95.11 crore during Q3FY25, change 21%. PBT: Rs 23.45 crore against Rs 14.06 crore during Q3FY25, change 67%. PAT: Rs 17.28 crore against Rs 10.4 crore during Q3FY25, change 66%. EPS: Rs 35.76 for Q3FY26. Result PDF